AAAAAA

   
Results: 1-2 |
Results: 2
CLINICAL AND IMMUNOLOGICAL EFFECTS OF T-ACTIVIN THERAPY IN EARLY-STAGE MELANOMA PATIENTS
Authors: STANOJEVICBAKIC N MILOSEVIC D VUCKOVICDEKIC L SASIC M MARKOVIC L
Citation: N. Stanojevicbakic et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF T-ACTIVIN THERAPY IN EARLY-STAGE MELANOMA PATIENTS, Neoplasma, 43(4), 1996, pp. 245-252
IMMUNOMODULATING EFFECT OF T-ACTIVIN THERAPY MODIFIER ON THE IMMUNO-SUPPRESSION CAUSED BY IN MELANOMA PATIENTS
Authors: STANOJEVICBAKIC N MILOSEVIC D VUCKOVICDEKIC L SASIC M MARKOVIC L
Citation: N. Stanojevicbakic et al., IMMUNOMODULATING EFFECT OF T-ACTIVIN THERAPY MODIFIER ON THE IMMUNO-SUPPRESSION CAUSED BY IN MELANOMA PATIENTS, European journal of cancer, 31A, 1995, pp. 596-596
Risultati: 1-2 |